Raymond James Financial Services Advisors’s Zomedica Corp. ZOM Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,915	Closed	-$3K	–	3449
2022 Q3	$3K	Buy	+15,915	New	+$4.21K	﹤0.01%	3243
2022 Q2	–	Sell	-38,115	Closed	-$13K	–	3495
2022 Q1	$13K	Buy	38,115 +14,000	+58%	+$4.58K	﹤0.01%	3283
2021 Q4	$7K	Sell	24,115 -3,900	-14%	-$1.76K	﹤0.01%	3279
2021 Q3	$15K	Sell	28,015 -35	-0.1%	-$21	﹤0.01%	3249
2021 Q2	$23K	Buy	28,050 +3,295	+13%	+$3.07K	﹤0.01%	3247
2021 Q1	$39K	Buy	+24,755	New	+$40.5K	﹤0.01%	3114

Other funds holding ZOM

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Raymond James Financial Services Advisors's ZOM Position: Q4 2022 in Review

Raymond James Financial Services Advisors sold out of Zomedica Corp. (ZOM) in Q4 2022, closing a stake of 15,915 shares — an estimated $3K sold.

Raymond James Financial Services Advisors first reported a position in ZOM in Q1 2021 and held it in 6 quarters. The position peaked at $39K in Q1 2021. 91 funds tracked by Wall St. Rank hold ZOM as of Q4 2022.

Raymond James Financial Services Advisors reported no remaining Zomedica Corp. position as of Q4 2022 after selling out during the quarter.
Raymond James Financial Services Advisors sold 15,915 Zomedica Corp. shares in Q4 2022, an estimated $3K.
Raymond James Financial Services Advisors first reported a position in Zomedica Corp. in Q1 2021 and held it in 6 quarters.
Raymond James Financial Services Advisors's Zomedica Corp. position peaked at $39K in Q1 2021.
91 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.